Peter Alping

12PUBLICATIONS
14CO-AUTHORS
Medical infection agents (incl. prions)Recommender systemsInfant and child healthRheumatology and arthritisRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 02, 2026
Comorbidities for Predicting Progression Independent of Relapse Activity in Multiple Sclerosis Treated With B-Cell Depletion.

|Jul 24, 2025
Completeness and generalizability of the Swedish MS register.

Peter Alping, Thomas Frisell, Anna He

|Feb 11, 2025
Validation of the Swedish Multiple Sclerosis registry for pediatric-onset multiple sclerosis.

Fredrik Sandesjö, Peter Alping, Katharina Fink

|Jul 10, 2024
Hospital-Treated Infections and Risk of Disability Worsening in Multiple Sclerosis.

Yihan Hu, Thomas Frisell, Peter Alping

|Jun 26, 2024
COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab.

Fredrik Piehl, Peter Alping, Suvi Virtanen

|Mar 26, 2024
Real-World Healthcare Cost Savings and Reduced Relapse Rate with Off-Label Rituximab versus Disease-Modifying Treatments Approved for Relapsing-Remitting Multiple Sclerosis: A Nationwide Cost-Effectiveness Study.

Peter Alping, Martin Neovius, Fredrik Piehl

Pageof 2

Frequent Collaborators

6 joint publications

Thomas Frisell

4 joint publications

Fredrik Piehl

2 joint publications

Simon Englund

2 joint publications

Annette M Langer-Gould